UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 534

Sortiert nach

TRIM26 inhibits hepatitis B virus replication by promoting HBx degradation and TRIM26 genetic polymorphism predicts PegIFNα treatment response of HBeAg‐positive chronic hepatitis B Patients

Alimentary pharmacology & therapeutics, 2022-09, Vol.56 (5), p.878-889

2022

Volltextzugriff (PDF)

Higher BST2 Expression Promotes the Anti‐HBV Effect of IFN‐α and BST2 Genetic Variant Predicts PegIFNα Treatment Response of HBeAg‐Positive Chronic Hepatitis B Patients

Clinical pharmacology and therapeutics, 2024-02, Vol.115 (2), p.361-370

2024

Volltextzugriff (PDF)

Editorial: tripartite motif 26 inhibits hepatitis B virus replication and its genetic polymorphism predicts response to interferon treatment—towards a better understanding of interferon responsiveness in chronic hepatitis B. Authors' reply

Alimentary pharmacology & therapeutics, 2022-09, Vol.56 (6), p.1096-1097

2022

Volltextzugriff (PDF)

CXCL13 variant predicts pegylated‐interferon α treatment response in HBeAg‐positive chronic hepatitis B patients

Journal of medical virology, 2023-07, Vol.95 (7), p.e28963-n/a

2023

Volltextzugriff (PDF)

TRIM16 E121D variant affects the risk and prognosis of hepatocellular carcinoma by modulating the Wnt/β-catenin pathway

Molecular carcinogenesis, 2023-11, Vol.62 (11), p.1686-1699

2023

Volltextzugriff (PDF)

The Role of ALPK1 in Inhibiting Hepatitis B Virus Replication Facilitates the Identification of ALPK1 P660L Variant for Predicting Response to Pegylated Interferon α Therapy

The Journal of infectious diseases, 2023-09, Vol.228 (6), p.694-703

2023

Volltextzugriff (PDF)

Implications of Stemness Features in 1059 Hepatocellular Carcinoma Patients from Five Cohorts: Prognosis, Treatment Response, and Identification of Potential Compounds

Cancers, 2022-01, Vol.14 (3), p.563

2022

Volltextzugriff (PDF)

A missense variant in complement factor B (CFB) is a potential predictor of 24‐week off‐treatment response to PegIFNα therapy in Chinese HBeAg‐positive chronic hepatitis B patients

Alimentary pharmacology & therapeutics, 2020-02, Vol.51 (4), p.469-478

2020

Volltextzugriff (PDF)

An enhancer variant at 16q22.1 predisposes to hepatocellular carcinoma via regulating PRMT7 expression

Nature communications, 2022-03, Vol.13 (1), p.1232-1232, Article 1232

2022

Volltextzugriff (PDF)

TP53 R249S mutation detected in circulating tumour DNA is associated with Prognosis of hepatocellular carcinoma patients with or without hepatectomy

Liver international, 2020-11, Vol.40 (11), p.2834-2847

2020

Volltextzugriff (PDF)

NLRC3 silencing accelerates the invasion of hepatocellular carcinoma cell via IL‐6/JAK2/STAT3 pathway activation

Cell biology international, 2020-10, Vol.44 (10), p.2053-2064

2020

Volltextzugriff (PDF)

Genetic variation in STAT4 predicts response to interferon‐α therapy for hepatitis B e antigen‐positive chronic hepatitis B

Hepatology (Baltimore, Md.), 2016-04, Vol.63 (4), p.1102-1111

2016

Volltextzugriff (PDF)

Genetic variants in five novel loci including CFB and CD40 predispose to chronic hepatitis B

Hepatology (Baltimore, Md.), 2015-07, Vol.62 (1), p.118-128

2015

Volltextzugriff (PDF)

Caspase polymorphisms and prognosis of hepatocellular carcinoma

PloS one, 2017-04, Vol.12 (4), p.e0176802-e0176802

2017

Volltextzugriff (PDF)

A Missense Variant in Granulysin is Associated with the Efficacy of Pegylated-Interferon-Alpha Therapy in Chinese Patients with HBeAg-Positive Chronic Hepatitis B

Pharmacogenomics and personalized medicine, 2021-01, Vol.14, p.1505-1515

2021

Volltextzugriff (PDF)

Pan-Cancer Analysis Identified C1ORF112 as a Potential Biomarker for Multiple Tumor Types

Frontiers in molecular biosciences, 2021-08, Vol.8, p.693651-693651

2021

Volltextzugriff (PDF)

A genetic variant of CXCR4 predicts pegylated interferon-alpha treatment response in HBeAg-positive chronic hepatitis B patients

Journal of clinical microbiology, 2024-02, Vol.62 (2), p.e0139623

2024

Volltextzugriff (PDF)

Performance of the Prostate Health Index in predicting prostate biopsy outcomes among men with a negative digital rectal examination and transrectal ultrasonography

Asian journal of andrology, 2016-07, Vol.18 (4), p.633-638

2016

Volltextzugriff (PDF)

Association between microRNA polymorphisms and cancer risk based on the findings of 66 case-control studies

PloS one, 2013-11, Vol.8 (11), p.e79584-e79584

2013

Volltextzugriff (PDF)

An intronic genetic variant of ZHX2 predicts response to pegylated interferon α therapy in HBeAg-positive chronic hepatitis B patients

Antiviral research, 2023-12, Vol.220, p.105741, Article 105741

2023

Volltextzugriff (PDF)

A functional variant of CD40 modulates clearance of hepatitis B virus in hepatocytes via regulation of the ANXA2/CD40/BST2 axis

Human molecular genetics, 2023-04, Vol.32 (8), p.1334-1347

2023

Volltextzugriff (PDF)

Identification of pyroptosis subtypes and prognosis model of hepatocellular carcinoma based on pyroptosis‐related genes

Cancer medicine (Malden, MA), 2024-08, Vol.13 (15), p.e70081-n/a

2024

Volltextzugriff (PDF)

TP53 Arg72Pro polymorphism is associated with esophageal cancer risk：A meta-analysis

World journal of gastroenterology : WJG, 2011-03, Vol.17 (9), p.1227-1233

2011

Volltextzugriff (PDF)

Variants in STAT4 Associated With Cure of Chronic HBV Infection in HBeAg-positive Patients Treated With Pegylated Interferon-alpha

Clinical gastroenterology and hepatology, 2020-01, Vol.18 (1), p.196-204.e8

2020

Volltextzugriff (PDF)

Prostate cancer antigen 3 and genetic risk score as markers for the detection of prostate cancer in the Chinese population

Asian journal of andrology, 2015-01, Vol.17 (1), p.168-170

2015

Volltextzugriff (PDF)

1 – 25 von 534

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(443)
Mit Volltextzugriff
(496)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(312)
Life Sciences & Biomedicine
(190)
Humans
(135)
Male
(80)
Female
(77)
Physical Sciences
(73)
Technology
(67)
Animals
(58)
Middle Aged
(56)
Oncology
(51)
Adult
(50)
Aged
(38)
Physics
(38)
Materials Science
(37)
Materials Science, Multidisciplinary
(35)
Engineering
(31)
Mice
(31)
Prognosis
(31)
Science & Technology - Other Topics
(29)
Hepatocellular Carcinoma
(28)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

TRIM26 inhibits hepatitis B virus replication by promoting HBx degradation and TRIM26 genetic polymorphism predicts PegIFNα treatment response of HBeAg‐positive chronic hepatitis B Patients

Higher BST2 Expression Promotes the Anti‐HBV Effect of IFN‐α and BST2 Genetic Variant Predicts PegIFNα Treatment Response of HBeAg‐Positive Chronic Hepatitis B Patients

Editorial: tripartite motif 26 inhibits hepatitis B virus replication and its genetic polymorphism predicts response to interferon treatment—towards a better understanding of interferon responsiveness in chronic hepatitis B. Authors' reply

CXCL13 variant predicts pegylated‐interferon α treatment response in HBeAg‐positive chronic hepatitis B patients

TRIM16 E121D variant affects the risk and prognosis of hepatocellular carcinoma by modulating the Wnt/β-catenin pathway

The Role of ALPK1 in Inhibiting Hepatitis B Virus Replication Facilitates the Identification of ALPK1 P660L Variant for Predicting Response to Pegylated Interferon α Therapy

Implications of Stemness Features in 1059 Hepatocellular Carcinoma Patients from Five Cohorts: Prognosis, Treatment Response, and Identification of Potential Compounds

A missense variant in complement factor B (CFB) is a potential predictor of 24‐week off‐treatment response to PegIFNα therapy in Chinese HBeAg‐positive chronic hepatitis B patients

An enhancer variant at 16q22.1 predisposes to hepatocellular carcinoma via regulating PRMT7 expression

TP53 R249S mutation detected in circulating tumour DNA is associated with Prognosis of hepatocellular carcinoma patients with or without hepatectomy

NLRC3 silencing accelerates the invasion of hepatocellular carcinoma cell via IL‐6/JAK2/STAT3 pathway activation

Genetic variation in STAT4 predicts response to interferon‐α therapy for hepatitis B e antigen‐positive chronic hepatitis B

Genetic variants in five novel loci including CFB and CD40 predispose to chronic hepatitis B

Caspase polymorphisms and prognosis of hepatocellular carcinoma

A Missense Variant in Granulysin is Associated with the Efficacy of Pegylated-Interferon-Alpha Therapy in Chinese Patients with HBeAg-Positive Chronic Hepatitis B

Pan-Cancer Analysis Identified C1ORF112 as a Potential Biomarker for Multiple Tumor Types

A genetic variant of CXCR4 predicts pegylated interferon-alpha treatment response in HBeAg-positive chronic hepatitis B patients

Performance of the Prostate Health Index in predicting prostate biopsy outcomes among men with a negative digital rectal examination and transrectal ultrasonography

Association between microRNA polymorphisms and cancer risk based on the findings of 66 case-control studies

An intronic genetic variant of ZHX2 predicts response to pegylated interferon α therapy in HBeAg-positive chronic hepatitis B patients

A functional variant of CD40 modulates clearance of hepatitis B virus in hepatocytes via regulation of the ANXA2/CD40/BST2 axis

Identification of pyroptosis subtypes and prognosis model of hepatocellular carcinoma based on pyroptosis‐related genes

TP53 Arg72Pro polymorphism is associated with esophageal cancer risk：A meta-analysis

Variants in STAT4 Associated With Cure of Chronic HBV Infection in HBeAg-positive Patients Treated With Pegylated Interferon-alpha

Prostate cancer antigen 3 and genetic risk score as markers for the detection of prostate cancer in the Chinese population

Suchergebnisse filtern